Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Polybrene (Hexadimethrine Bromide) 10 mg/mL: Precision for C
2026-07-09
This article examines real-world laboratory challenges and evidence-based solutions provided by Polybrene (Hexadimethrine Bromide) 10 mg/mL (SKU K2701). Through scenario-driven Q&A, it addresses reproducibility, assay sensitivity, and workflow optimization for gene transduction and transfection. Researchers will gain practical, validated best practices for leveraging SKU K2701 in demanding cellular assays.
-
Selective Spectrophotometric Determination of β-Lactam Antib
2026-07-09
This study introduces two optimized spectrophotometric methods for the selective quantification of phenolic β-lactam antibiotics, including combinations with dicloxacillin, in pure and formulated samples. The protocols offer a practical advance for routine quality control and address analytical gaps left by standard chromatographic techniques.
-
Plerixafor (AMD3100): CXCR4 Inhibition for Cancer and Stem C
2026-07-08
Plerixafor (AMD3100) is a potent CXCR4 inhibitor used in cancer metastasis and hematopoietic stem cell mobilization research. Its high specificity and well-characterized action make it a benchmark reagent for dissecting the CXCL12/CXCR4 axis in oncology and immunology. APExBIO supplies validated Plerixafor (A2025) for reproducible experimental workflows.
-
Trelagliptin Succinate: Novel Insights Beyond Glycemic Contr
2026-07-08
Explore Trelagliptin succinate’s multifaceted mechanism, including its emerging role in osteoblastic differentiation and diabetes mellitus research. This article goes beyond standard protocols to reveal practical, reference-backed assay implications.
-
Icatibant’s Role in Hantavirus and COVID-19: Clinical Insigh
2026-07-07
This article examines the clinical innovation of using icatibant, a bradykinin receptor antagonist, in the management of severe viral infections such as nephropathia epidemica (NE) and COVID-19. The reference study highlights its mechanistic rationale, patient outcomes, and the significance for future translational infection research.
-
Toxicological Profile of Decitabine in Murine Antileukemic M
2026-07-07
This study by Momparler & Frith systematically characterizes the acute and reversible toxic effects of Decitabine (5-Aza-2'-deoxycytidine) in mice, providing foundational data for its clinical translation in hematopoietic malignancy research. The findings inform both dosage safety and mechanistic understanding critical for cancer epigenetics workflows.
-
Redefining In Vitro Drug Response Evaluation in Cancer Resea
2026-07-06
Schwartz's dissertation introduces a nuanced framework for evaluating anticancer drug effects in vitro, distinguishing between proliferative arrest and cell death. These insights offer researchers a more accurate understanding of drug mechanisms, informing both assay design and translational relevance.
-
Streptavidin-FITC: Precision Biotin Detection for Advanced W
2026-07-06
Streptavidin-FITC enables ultrasensitive, quantitative detection of biotinylated molecules in immunofluorescence, flow cytometry, and nanoparticle trafficking studies. Its high-affinity binding and robust fluorescence empower researchers to tackle complex intracellular assays with confidence and reproducibility.
-
Podophyllotoxin: Mechanistic Leverage for Overcoming Cancer
2026-07-05
Podophyllotoxin’s dual action as a microtubule inhibitor and apoptosis inducer is reshaping strategies in anticancer drug research, particularly in the context of multidrug resistance (MDR). This thought-leadership article provides translational researchers with mechanistic insights, protocol guidance, and a strategic vision for leveraging podophyllotoxin and its derivatives in high-impact oncology studies. Integrating recent findings and established workflows, we explore how APExBIO’s podophyllotoxin (SKU N1790) empowers reproducibility and innovation in cell cycle, autophagy, and hepatocellular carcinoma models.
-
CDK4/6 and BET Inhibition Suppresses EMT in Pancreatic Cance
2026-07-04
Gu et al. (2025) demonstrate that dual targeting of CDK4/6 and BET proteins synergistically inhibits both tumor growth and epithelial-mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDAC) by modulating the GSK3β-mediated Wnt/β-catenin pathway. These findings suggest a promising strategy to overcome metastasis and resistance mechanisms in PDAC research.
-
Streptavidin-FITC: Advanced Fluorescent Detection Workflows
2026-07-03
Streptavidin-FITC delivers unparalleled sensitivity for biotin-labeled target detection in immunohistochemistry, flow cytometry, and nanoparticle tracking. This guide translates the latest research and practical troubleshooting into actionable protocols that maximize signal fidelity and workflow flexibility.
-
IGF2BP1-m6A-TUBB4B Axis Drives Hepatic Stellate Cell Activat
2026-07-03
This study uncovers how the m6A reader protein IGF2BP1 promotes hepatic stellate cell activation by stabilizing TUBB4B mRNA, elucidating a new molecular pathway in liver fibrosis. The IGF2BP1/TUBB4B/FAK axis emerges as a promising target for developing antifibrotic therapies.
-
MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi
2026-07-02
The referenced study identifies MAPK10 as a key suppressor of non-small cell lung cancer (NSCLC) metastasis through phosphorylation-dependent ubiquitination and degradation of keratin 16. These mechanistic insights position the MAPK10/KRT16/RNF213 axis as a promising prognostic and therapeutic target in NSCLC, with significant implications for protein-based biomarker discovery.
-
GTP Solution in mRNA Synthesis: Protocols and Troubleshootin
2026-07-02
GTP Solution (100 mM) stands at the core of in vitro mRNA synthesis for next-generation therapies, including tumor suppressor replacement in bladder cancer. This guide details robust workflows, optimization strategies, and key innovations that leverage high-purity guanosine-5'-triphosphate for superior RNA yields and translational impact.
-
Polybrene (Hexadimethrine Bromide): Precision Tools for Vira
2026-07-01
Polybrene (Hexadimethrine Bromide) 10 mg/mL supercharges viral gene delivery and DNA transfection, bridging fundamental research with translational impact. Its unique charge-based mechanism and versatility across peptide sequencing and anti-heparin applications set it apart as an essential laboratory reagent.